![Dr Moira Cruickshank Dr Moira Cruickshank](/img/200x200/staffpages/uploads/mmd982/DSC_1210_copy.jpg)
Research Fellow
- About
-
- Email Address
- m.cruickshank@abdn.ac.uk
- Office Address
Health Services Research Unit
3rd Floor Health Sciences Building
Foresterhill
Aberdeen
AB25 2ZD- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Moira Cruickshank is a Research Fellow in the Evidence Synthesis programme of HSRU.
Moira was a Police Officer in the Metropolitan Police for 13 years before returing to full time education at the University of Aberdeen in 2002. She graduated with BSc (Hons) Psychology in 2006 and MRes Psychology in 2007. Moira then undertook a PhD in Psychology within HSRU, supervised by Prof Jill Francis, Dr Rachael Powell and Prof James N'Dow. The PhD was funded by UCAN, a local charity aiming to improve the experience and outcomes of people diagnosed with urological cancer. Since completing her PhD in 2011, Moira has been a systematic reviewer within the Evidence Synthesis programme and is involved in technology assessment appraisals and health technology assessment reviews.
- Publications
-
Page 1 of 4 Results 1 to 10 of 39
What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence
PloS ONE, vol. 19, no. 3 , e0299743Contributions to Journals: Review articlesCost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels
Andrology, vol. 12, no. 3, pp. 477-486Contributions to Journals: ArticlesIvosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
National Institute for Health and Care Excellence (NICE). 20 pagesBooks and Reports: Commissioned Reports- [ONLINE] https://www.nice.org.uk/guidance/ta948
- [ONLINE] Page 214-316
- [ONLINE] https://www.nice.org.uk/guidance/ta948/evidence
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 4, no. 10, pp. e561-e572Contributions to Journals: ArticlesDeucravacitinib for treating moderate-to-severe plaque psoriasis
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 155 pagesBooks and Reports: Commissioned ReportsManagement of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence
Journal of Neurology, vol. 269, no. 7, pp. 3420-3429Contributions to Journals: Review articlesAxicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after one systemic therapy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 128 pagesBooks and Reports: Commissioned ReportsAdverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 3, no. 6, pp. e381–393Contributions to Journals: ArticlesDoes weight management research for adults with severe obesity represent them? Analysis of systematic review data
BMJ Open, vol. 12, no. 5, e054459Contributions to Journals: ArticlesIdentifying the outcomes important to men with hypogonadism: a qualitative evidence synthesis
Journal of Andrology, vol. 10, no. 4, pp. 625-641Contributions to Journals: Articles